强生Johnson & Johnson (JNJ) 2018年年度报告「NYSE」.pdf

1、2018A N N U A L R E P O R T I have the privilege of being the CEO of Johnson&Johnson during a remarkable time in history.Throughout my seven years in this role,there have been many dramatic changesin global politics,the world economy,science,technology and culture.At the same time,there has also bee

2、n an accelerated pace of progress in human health:unlocking the possibilities of the human genome,evolving and expanding theuse of robotics and micro surgery,extending the life expectancy for people with HIV,and continuing to wage and win the fight againstcancer and other debilitating diseases thath

3、ave resisted treatment for generations.Whats most exciting about this progress is that Johnson&Johnson has been at thevery forefront of many of these revolutionarychanges and expanding horizonstimeand time again,delivering life-saving medicines and life-changing solutions.It is an honor to lead an i

4、nnovation-driven culturethat continues to demonstrate the energy,driveand passion of a“start-up.”However,we also have the distinct advantage of our timelessvalues,such as the strong influence of our long-term strategic view,the unwaveringguidance of Our Credo and the profound wayin which we measure

5、progress and success.Our Credo challenges us to focus on improvingoutcomes for patients and consumers globally,while we also focus on improving revenueI have the privilege of being the CEO of I have the privilege of being the CEO of I have the privilege of being the CEO ofJohnson&Johnson during a re

6、markable time Johnson&Johnson during a remarkable time Johnson&Johnson during a remarkable timein history.Throughout my seven years in this in history.Throughout my seven years in this in history.Throughout my seven years in thisrole,there have been many dramatic changesrole,there have been many dra